F Piscaglia

Author PubWeight™ 65.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2012 4.21
2 Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001 4.12
3 Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 2008 3.49
4 EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med 2013 2.93
5 EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 2013 2.73
6 Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999 2.30
7 Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2010 2.09
8 Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008 2.06
9 What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997 1.98
10 Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig Liver Dis 2008 1.65
11 Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004 1.44
12 Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 1999 1.43
13 An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med 2012 1.29
14 Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001 1.12
15 Ultrasound in portal hypertension--part 2--and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med 2012 1.07
16 New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 2007 1.04
17 High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997 1.03
18 High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? Gut 2006 1.00
19 Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". J Hepatol 2012 0.97
20 Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study. Aliment Pharmacol Ther 2012 0.91
21 Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography. Dig Liver Dis 2004 0.91
22 Assessment of vascular patterns of small liver mass lesions: value and limitation of the different Doppler ultrasound modalities. Am J Gastroenterol 2000 0.90
23 Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2006 0.89
24 Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. Clin Exp Immunol 1999 0.89
25 Influence of esophageal varices and spontaneous portal-systemic shunts on postprandial splanchnic hemodynamics. Am J Gastroenterol 2001 0.87
26 Ultrasound in portal hypertension--part 1. Ultraschall Med 2011 0.86
27 Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006 0.84
28 Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. Clin Cancer Res 1999 0.84
29 Sonographic assessment of the distal end of the thoracic duct in healthy volunteers and in patients with portal hypertension. AJR Am J Roentgenol 1995 0.84
30 Vascularity of liver tumours and recent advances in doppler ultrasound. J Hepatol 2001 0.83
31 Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med 2009 0.83
32 Liver cirrhosis, ascites, and hyperfibrinolysis. Am J Gastroenterol 2001 0.82
33 Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. Aliment Pharmacol Ther 2007 0.82
34 Hemodynamics in focal nodular hyperplasia. J Hepatol 1999 0.82
35 Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation. Aliment Pharmacol Ther 2008 0.81
36 [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis]. Radiol Med 1998 0.81
37 Circadian occurrence of variceal bleeding in patients with liver cirrhosis. J Gastroenterol Hepatol 1996 0.80
38 Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax. Ultraschall Med 2008 0.78
39 Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation. Endoscopy 2011 0.77
40 Review article: liver transplantation for HCC. Treatment options on the waiting list. Aliment Pharmacol Ther 2003 0.77
41 Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc 2008 0.76
42 Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria (Br J Surg 2011; 98: 1201-1208). Br J Surg 2011 0.76
43 Review article: percutaneous treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2003 0.76
44 Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study. Liver 1996 0.76
45 Management of small hepatocellular carcinoma. Acta Gastroenterol Belg 2006 0.76
46 Intrahepatic artery pseudoaneurysm: a possible complication of blind thoracentesis. J Clin Ultrasound 1999 0.76
47 Role of real-time contrast-enhanced ultrasound in the assessment of metastatic portal vein thrombosis. Ultraschall Med 2007 0.76
48 Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. Ital J Gastroenterol Hepatol 1997 0.76
49 Cigarette smoking, abdominal blood flow and abdominal diseases. J Gastroenterol Hepatol 1996 0.75
50 Left ventricular function in liver cirrhosis. J Hepatol 1996 0.75
51 Prophylaxis of post-ERCP pancreatic complications with gabexate. Dig Liver Dis 2007 0.75
52 Splanchnic arterial Doppler parameters in portal hypertension. Hepatology 1999 0.75
53 Diagnosis and management of hepatic focal nodular hyperplasia. J Ultrasound 2007 0.75
54 Diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol 1998 0.75
55 Hepatic artery resistance in portal vein thrombosis. Radiology 1996 0.75
56 Possible mechanisms for changes of intrasplenic arterial impedance indices in portal hypertension. Hepatology 1997 0.75
57 Cardiac abnormalities in cirrhosis. Am J Gastroenterol 2001 0.75
58 Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? Ultraschall Med 2013 0.75
59 The chronically ill elderly patients discharged from the hospital: interim report from a controlled study of home care attendance. Arch Gerontol Geriatr Suppl 2004 0.75
60 Nodule in nodule: malignant transformation of a macroregenerative nodule in cirrhosis revealed by duplex-Doppler. J Hepatol 1999 0.75
61 Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate. Dig Dis Sci 2000 0.75
62 [Ultrasound: the only "one stop shop" for modern management of liver disease]. Ultraschall Med 2013 0.75